Formamide Market Dynamics Report (Recent Commodity Market Intelligence)

I. Price Dynamics
1. Benchmark Price:
- According to B2B chemical platform Shengyishe, the benchmark price of formamide on May 26, 2026, stood at RMB 5,266.67 per metric ton, unchanged from the beginning of the month and positioned at a mid-to-lower level within the annual range.
- Annual price fluctuation range: annual low of RMB 5,025.00/ton; annual high of RMB 5,850.00/ton; median value of RMB 5,437.50/ton.

2. Regional Quotations:
- Shandong Province:
Zibo City: Domestic national-standard premium-grade ex-factory price: RMB 5,500.00/ton; Shandong top-grade (purity ≥99.9%) ex-factory price: RMB 4,400.00/ton; market price: RMB 4,500.00/ton.
Weifang City: Guizhou Tianfu product (purity >99.5%, packaged in 220-kg drums or 30-ton tank trucks) market price: RMB 5,200.00/ton; Shandong bulk (purity ≥99.5%) market price: RMB 5,000.00/ton.
- Henan Province: 99% purity formamide market price: RMB 5,200.00/ton; pharmaceutical-grade formamide spot price: RMB 6,650–6,800/ton (minimum order quantity ≥1 ton).

3. Historical Trend:
- From December 2025 to May 2026, formamide prices exhibited an initial upward movement followed by stabilization: average price in December 2025 was approximately RMB 5,000/ton; prices briefly rose to ~RMB 5,100/ton in January–February 2026 before declining; March–May 2026 saw stable trading in the RMB 5,200–5,300/ton range.

II. Supply-Demand Analysis
1. Supply Side:
- Domestic production capacity is concentrated among enterprises such as Suqian Xinya (Jiangsu), Feicheng Asder (Shandong), and Chongqing Wanlilai. Suqian Xinya alone accounts for over 50% of domestic market share.
- Global CR5 (top five producers’ combined market share) for formamide reached 52% in 2025. Environmental regulations have accelerated the exit of inefficient capacity, optimizing the industry’s supply structure.

2. Demand Side:
- China’s annual demand volume stands at approximately 50,000 metric tons, with over 80% consumed as a key raw material in pharmaceutical and agrochemical synthesis. Downstream applications include plywood adhesives, synthetic resins, and vinylon fiber.
- Pharmaceutical demand growth has been particularly robust: R&D for mRNA vaccine adjuvants, anticancer drugs, and biologics has driven annual growth in high-purity formamide demand at a rate 2–3 percentage points faster than overall market growth.

3. Regional Supply-Demand Balance:
- Asia remains the world’s largest market. New capacity expansions in Southeast Asia have led to relatively loose supply conditions. Europe faces local supply deficits due to elevated energy costs and relies heavily on imports. North America maintains a stable market share.

III. Cost and Policy Impacts
1. Raw Material Costs:
- Formamide production is highly dependent on methanol, liquid ammonia, and natural gas. In 2025, international methanol and liquid ammonia prices rose year-on-year by 8%–12%; European natural gas prices increased by approximately 15% YoY—directly elevating manufacturing costs.

2. Environmental Regulations:
- The EU’s REACH regulation has listed NMF (N-Methylformamide) as a substance requiring authorization, raising barriers to both production and importation and resulting in reduced effective capacity in Europe. In China and Southeast Asia, intensified environmental inspections are accelerating the elimination of outdated capacity, further increasing industry concentration.

IV. Analysis, Outlook & Strategic Recommendations
1. Short-Term Outlook (June–December 2026):
- Price Trend: Potential commissioning of new methanol capacity may exert mild downward pressure on formamide prices (–2% to –3%), yet cost support remains firm; prices are expected to trade within RMB 5,000–5,300/ton.
- Regional Price Differentials: Exchange rate volatility and logistics cost fluctuations may widen inter-regional price spreads; European prices are likely to remain elevated due to persistent supply gaps.

2. Medium-to-Long-Term Outlook (2027–2030):
- Demand Growth: Sustained expansion in demand for high-purity formamide from pharmaceuticals and electronics sectors—including semiconductors and biopharmaceuticals—will serve as enduring growth drivers.
- Supply Transformation: Industrial-scale adoption of bio-based synthesis routes could reshape feedstock structures and cost frameworks. Converging global environmental standards will further constrain the operational viability of legacy, non-compliant capacity.
- Price Trajectory: A cost-supported upward shift in the pricing center is anticipated. Prices for high-purity grades (e.g., pharmaceutical-grade) are projected to rise steadily (+3% to +5%).

3. Strategic Recommendations:
- Enterprises should intensify R&D investment and regulatory certification efforts targeting electronic-grade and pharmaceutical-grade products to capture high-value market segments.
- Build diversified raw material sourcing networks and cross-regional production footprints to mitigate energy and logistics risks.
- Proactively develop low-carbon manufacturing processes and circular economy models to align with evolving regulatory requirements and customer ESG (Environmental, Social, Governance) expectations.